Results 121 to 130 of about 20,583 (144)

[Pharmacokinetic monitoring of isavuconazole in a patient with extracorporeal membrane oxygenation support]. [PDF]

Rev Esp Quimioter
Herranz-Bayo E, Huarte-Lacunza R, Sánchez-Chueca P, Aguiló-Lafarga I, Pinilla-Rello A, Sampedro-Calavia E.   +5 more
europepmc   +1 more source

Voriconazole Pharmacokinetics Administered at 4 mg/kg IM and IV in Nursehound Sharks (<i>Scyliorhinus stellaris</i>) Under Human Care. [PDF]

Vet Sci
Cañizares-Cooz D, García-Párraga D, Rubio-Langre S, Encinas T, Morón-Elorza P.   +4 more
europepmc   +1 more source

[Advances and guidance in the treatment of drug-resistant epilepsy: a review by the Andalusian Epilepsy Society of the new drugs cenobamate, fenfluramine and cannabidiol]. [PDF]

Rev Neurol
Arenas-Cabrera C, Cabezudo-García P, Calvo-Medina R, Galeano-Bilbao B, Martínez-Agredano P, Ruiz-Giménez J, Rodríguez-Uranga JJ, Quiroga-Subirana P.   +7 more
europepmc   +1 more source

Geriatric cardiology. [PDF]

Arch Cardiol Mex
Lasses-Y-Ojeda LA.
europepmc   +1 more source

“SEDACIÓN POSTOPERATORIA EN PACIENTES PREMEDICADOS CON DEXMEDETOMIDINA SOMETIDOS A RINOSEPTOPLASTIA COMPARADA CON MIDAZOLAM” [PDF]

, 2014
Márquez Zapien, Cuitláhuac, Zaragoza Alvarez, Manuel   +1 more
core  

Consideraciones farmacológicas en la anestesia del paciente pediátrico obeso [PDF]

Revista Chilena de Anestesia
Ibacache Figueroa Mauricio
doaj   +1 more source

[Inhaled levodopa: from evidence to experience]. [PDF]

Rev Neurol
Martínez-Castrillo JC, Pareés-Moreno I, López Sendón-Moreno JL, Pérez-Torre P, Fanjul S, Patiño-Patón A, García-Ribas G, Alonso-Cánovas A.   +7 more
europepmc   +1 more source

Therapeutic approach in the critically ill patient with suspected multidrug resistance. [PDF]

Rev Esp Quimioter
Soriano-Cuesta MC, López-Olivencia M, Candel FJ, García-Plaza S.   +3 more
europepmc   +1 more source

Analysis of omission of antimicrobial doses in Intensive Care Units. [PDF]

Rev Bras Enferm
Machado IR, Henrique DM, Camerini FG, Paula VG, Fassarella CS, Mello LRG.   +5 more
europepmc   +1 more source